WRB · Q1 2026 Earnings
BullishW. R. Berkley Corporation
Reported April 21, 2026
30-second summary
Berkley printed Q1 2026 with a 90.7% combined ratio, 21.2% ROE, and $3.69B revenue (+4.0% YoY), with Insurance NPW reaccelerating to +3.2% and Reinsurance & Monoline Excess NPW contracting -10.1% as the 1/1 pullback management flagged last quarter showed up sharply. The signal worth flagging: Rob Berkley explicitly said the company is "actively rethinking the balance between rate versus growth" and may "take our foot slightly off the rate pedal" — a direct reversal from the rate-discipline posture that has anchored every call since Q2 2025. Combined with the explicit commitment to "significant amounts of capital to return to shareholders for the foreseeable future," this is the first call in the visible run where Berkley is leaning into the cycle rather than defending against it.
Headline numbers
EPS
Q1 FY2026
$1.30
Revenue
Q1 FY2026
$3.69B
+4.0% YoY
Operating margin
Q1 FY2026
13.9%
Key financials
Q1 FY2026| Metric | Q1 FY2026 | YoY | Q4 FY2025 | QoQ |
|---|---|---|---|---|
| Revenue | $3.69B | +4.0% | $3.72B | -0.8% |
| EPS | $1.30 | — | $1.13 | +15.0% |
| Operating margin | 13.9% | — | — | — |
Guidance
Berkshire Hathaway reaffirmed full-year 2026 guidance across expense ratio, effective tax rate, and ROE targets; Q1 FY2026 results exceeded profitability expectations with 21.2% ROE and 28.6% expense ratio.
Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.
Reaffirmed unchanged this quarter: Effective tax rate (approximately 23%), Expense ratio (comfortably below 30%), After-tax return on equity (exceed 15% target)
Segment performance
Q1 FY2026| Segment | Q1 FY2026 | YoY |
|---|---|---|
| Insurance | $2.78B | +3.2% |
| Reinsurance & Monoline Excess | $0.39B | -10.1% |
| Other Liability | $1.12B | +1.0% |
| Short-tail lines | $0.63B | +5.2% |
| Auto | $0.42B | +7.4% |
| Professional Liability | $0.28B | +10.2% |
Capital & returns
Q1 FY2026| Segment | Q1 FY2026 |
|---|---|
| Return on Equity (ROE) | 21.2% |
| Operating ROE | 21.2% |
Other KPIs
Q1 FY2026| Segment | Q1 FY2026 |
|---|---|
| Combined Ratio (GAAP) | 90.7% |
| Accident Year Combined Ratio (ex-Catastrophe) | 88.3% |
| Loss Ratio | 62.1% |
| Expense Ratio | 28.6% |
| Net Investment Income Growth YoY | 12.2% |
| Average Rate Increase (ex-Workers' Comp) | 7.2% |
Management tone
Narrative arc: Q2 growth-runway-reset → Q3 cautious-margin-defense → Q4 confident-investment-cycle-pivot → Q1 rate-to-growth-rebalancing.
The most consequential tone shift in the visible run of calls happened this quarter on rate discipline. For three straight quarters — Q2's 8–12% growth-envelope walk-down, Q3's "we are in business to make good risk-adjusted returns, not solely to issue insurance policies," Q4's auto-and-property pullback framing — Berkley has anchored on rate-over-growth with increasing assertiveness. This quarter Rob reversed that: "We are actively rethinking what the balance is between rate versus growth. And over the coming quarters, you may see us take our foot slightly off the rate pedal and look to push harder on the growth in particular lines where we see the margin is particularly attractive." The signal is that management believes margin cushion is now wide enough — 88.3% accident year ex-cat — that giving up rate to capture volume in select lines is a positive ROE trade. This is the language of a company that thinks it has called the cycle peak correctly and now wants to deploy.
The cycle metaphor itself escalated meaningfully. One quarter ago management framed the marketplace as "more challenging more quickly" and described property-cat contagion as a structural problem. This quarter Rob offered a more confident framing: "the cycle is driven by two human emotions, greed and fear. And without a doubt, these days, it would seem as though the fear is fading and the greed is fully percolating." That sentence is doing real work — it tells you management believes peer underwriting is degrading, which is precisely the moment when a disciplined writer earns excess returns. The opportunism is grounded in a view that the cycle is in expansion phase, not in any specific Berkley capability.
Capital return language stepped up another notch. Q4 retired the "capital is accumulating, we don't need to deploy" framing in favor of $608M of returns including a record $377.9M special dividend. This quarter raised the ante explicitly: "We are generating capital significantly more quickly than we can consume it and that we will have significant amounts of capital to return to shareholders for the foreseeable." Crucially, the Andrew Kligerman Q&A confirmed leverage at 22.6% is viewed as comfortable — not a floor to ratchet down further. The signal: capital returns are now part of the structural earnings story, not an episodic top-up, and the buyback cadence Q4 set is intended to be sustainable rather than opportunistic.
The reinsurance posture inverted to active buyer. For multiple quarters Berkley has framed reinsurance as a discipline-deteriorating segment to shrink on the assumed side. This quarter Rob explicitly framed Berkley's gross-versus-net position as evidence that "this is probably a moment…where it's better to be a buyer of reinsurance than a seller of reinsurance." That is operational, not rhetorical — the -10.1% NPW contraction in Reinsurance & Monoline Excess is the assumed-side shrink, and the ceded book is correspondingly growing. The takeaway is that Berkley is now buying capacity from peers whose pricing is irrational, which compounds the margin advantage if the cycle softens further.
Recurring themes management leaned on this quarter:
Risks management surfaced:
Q&A highlights
Elise Greenspan · Wells Fargo
Clarification on management's opening comments regarding market competitiveness and greed/fear dynamics, and reconciling this with expectations for premium growth acceleration in Q2 given the commentary about better opportunities to push for less price and show better growth.
Management clarified that while the overall market is more competitive, there remain pockets of opportunity, particularly in casualty lines. Growth improvement is hoped for in Q2 but cannot be promised, as the company quotes 60-90+ days in advance and it takes time for pricing strategy pivots to materialize into written premium.
Rob Cox · Goldman Sachs
Property market pricing adequacy by ROE and by segment (insurance, reinsurance, geography), and color on professional lines growth drivers given strong results and whether that was pricing or exposure-driven.
Management indicated margins are still available but falling quickly, with reinsurance declining fastest, followed by cat-exposed property, and admitted/standard property least affected. Professional lines growth was primarily exposure-driven from outside the US; US-focused concerns remain around public D&O and EPLI. Declined to disclose specific regional opportunity metrics.
Andrew Kligerman · TD Cowen
Capital allocation priorities (buyback vs. dividend vs. growth in challenged market), rationale for large Q1 2025 buyback ($302M vs. full year 2024), and appropriate leverage ratio target.
Management emphasized that 22.6% leverage is sustainable, not too low. Large buyback was driven by strong capital generation (20%+ returns, ~$2B net income) with limited growth opportunities at historical rates. Company evaluates capital return methods (buyback, special dividend) based on valuation and growth opportunities at any moment; declines to provide specific guidance on future capital return roadmap.
Alex Scott · Barclays
Reinsurance market buying vs. selling appetite and any unusual items in premium growth (restatements, etc.). Also requested commentary on casualty reserve development trends (shorter-tail releasing vs. longer-tail building).
No unusual items in reinsurance premium numbers; decline reflects market conditions, competitive market, and some cedents increasing net retention to bolster top line. Management declined to provide detailed casualty reserve commentary on call but offered to discuss offline with analyst, citing information already disclosed in supplements and triangles.
Michael Zaremski · BMO Capital Markets
How Berkeley views loss-cost trend in social inflationary lines (GL, umbrella, commercial auto) and whether management is willing to disclose trend assumptions. Follow-up on debt-to-capital and circumstances for increasing leverage.
Management declined to disclose trend assumptions by product line but emphasized constant monitoring of internal and external data (traditional and nontraditional), with active pricing and selection response. On leverage, management noted the long-term range has been low 20s to mid 30s, averaging 30+; flexibility exists to increase leverage if market opportunities emerge, but company is comfortable at current levels.
Answers to last quarter's watch list
What to watch into next quarter
Does the rate-vs-growth pivot translate to written premium in Q2? Management explicitly said acceleration is hoped for but not promised, and 60-90+ day quoting lags will delay impact. Watch whether Insurance NPW prints above +5% in Q2 — anything still in the +3% range would suggest the pivot is rhetoric ahead of action.
Reinsurance & Monoline Excess NPW trajectory after the -10.1% Q1 shock. Watch whether Q2 stabilizes around -5% to -10% (confirming a step-change to the new operating zone) or worsens toward -15%+ (signaling the property-into-casualty contagion is still accelerating). The "buyer not seller" framing should be measurable in the ceded ratio.
Expense ratio progression as tech/AI spend ramps. 28.6% in Q1 is up 40bps sequentially. Watch whether Q2 crosses 29.0% — that would mark the first material step toward the "comfortably below 30%" ceiling and force a reassessment of whether the 21% ROE can absorb the investment cycle without rate-side compensation.
Net investment income dollar level and yield commentary. With +12.2% YoY growth confirmed but the absolute dollar figure not yet visible to this brief, watch whether Q2 NII clears $380M (above the H1 2025 quarterly run-rate) and whether new-money-vs-book-yield spread compression begins.
Capital return mix in Q2. Management's "significant…for the foreseeable" language sets a high bar. Watch for whether Q2 brings another special dividend, sustained buyback at the Q1 pace, or a step-down — and whether leverage drifts further below 22.6% (which Rob Berkley said he does not expect).
Sources
- W. R. Berkley Corporation Q1 2026 press release (8-K Exhibit 99.1), filed 2026-04-21: https://www.sec.gov/Archives/edgar/data/11544/000001154426000008/wrb33120268-kex991.htm
- Q1 2026 earnings call commentary (Rob Berkley remarks and Q&A, as cited in tone and Q&A extractions).
Get the next brief, free.
We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.